Sign In
Buy IOVA
Iovance Biotherapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 87.64. In total, the insiders bought 3.13M and sold 282.82K IOVA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
87.64 |
| ● Buy | 3.13M shares |
| ● Sell | 282.82K shares |
|
74% Buy Activity
Weak Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Mar 02, 2026 Sell |
Vogt Frederick G Interim CEO & General Counsel |
22 809 Value: $86.4K |
||
|
Mar 02, 2026 Buy |
Vogt Frederick G Interim CEO & General Counsel |
52 087 Value: $197.4K |
||
|
Mar 02, 2026 Buy |
Vogt Frederick G Interim CEO & General Counsel |
41 669 Value: $157.9K |
||
|
Mar 02, 2026 Buy |
Bilinsky Igor Chief Operating Officer |
12 307 Value: $46.6K |
||
|
Mar 02, 2026 Buy |
Bilinsky Igor Chief Operating Officer |
8 790 Value: $33.3K |
||
|
Mar 02, 2026 Buy |
Puri Raj K. Chief Regulatory Officer |
5 470 Value: $20.7K |
||
|
Mar 02, 2026 Buy |
Puri Raj K. Chief Regulatory Officer |
5 470 Value: $20.7K |
||
|
Mar 02, 2026 Buy |
Graf Finckenstein Friedrich Chief Medical Officer |
12 697 Value: $48.1K |
||
|
Mar 02, 2026 Sell |
Graf Finckenstein Friedrich Chief Medical Officer |
7 122 Value: $27.0K |
||
|
Mar 02, 2026 Buy |
Graf Finckenstein Friedrich Chief Medical Officer |
8 790 Value: $33.3K |
||
|
Mar 02, 2026 Buy |
Graf Finckenstein Friedrich Chief Medical Officer |
3 907 Value: $14.8K |
||
|
Feb 24, 2026 Buy |
Kirby Daniel Gordon Chief Commercial Officer |
150 000 Value: $567.0K |
||
|
Feb 24, 2026 Buy |
Kirby Daniel Gordon Chief Commercial Officer |
120 000 Value: $453.6K |
||
|
Feb 24, 2026 Sell |
Kirby Daniel Gordon Chief Commercial Officer |
34 165 Value: $129.1K |
||
|
Feb 10, 2026 Sell |
Kirby Daniel Gordon Chief Commercial Officer |
16 450 Value: $42.8K |
||
|
Feb 10, 2026 Buy |
Kirby Daniel Gordon Chief Commercial Officer |
39 996 Value: $104.0K |
||
|
Feb 10, 2026 Buy |
Kirby Daniel Gordon Chief Commercial Officer |
39 996 Value: $104.0K |
||
|
Dec 02, 2025 Buy |
Vogt Frederick G Interim CEO & General Counsel |
10 417 Value: $22.2K |
||
|
Dec 02, 2025 Sell |
Vogt Frederick G Interim CEO & General Counsel |
4 426 Value: $9K |
||
|
Dec 02, 2025 Buy |
Vogt Frederick G Interim CEO & General Counsel |
10 417 Value: $22.2K |
||
|
Dec 02, 2025 Buy |
Bilinsky Igor Chief Operating Officer |
3 516 Value: $8K |
||
|
Dec 02, 2025 Buy |
Bilinsky Igor Chief Operating Officer |
3 516 Value: $8K |
||
|
Dec 02, 2025 Sell |
Graf Finckenstein Friedrich Chief Medical Officer |
1 984 Value: $4K |
||
|
Dec 02, 2025 Buy |
Graf Finckenstein Friedrich Chief Medical Officer |
3 906 Value: $8K |
||
|
Dec 02, 2025 Buy |
Graf Finckenstein Friedrich Chief Medical Officer |
3 906 Value: $8K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
